Home > Insider Trading > Filing (0000910680-10-000010)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
885317	Ophthalmic Imaging Systems	OISI	Surgical & Medical Instruments & Apparatus (3841)	943035367

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1321178	Moshe Arkin	6 Hachoshlim St Herzelia L3	No	No	Yes	No
1467668	Ltd. (2009) Management Accelmed A.m.	6 Hachoshlim St Herzelia L3	No	No	Yes	No
1467669	Ltd. (1999) Arkin M.	6 Hachoshlim St Herzelia L3	No	No	Yes	No
1467670	U.m. Accelmed, Limited Partnership	6 Hachoshlim St Herzelia L3	Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-01-06	124,286	$0.70	9,757,514	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

On January 6, 2010, MediVision Medical Imaging Ltd. ("MediVision") sold 124,286 shares of common stock, no par value per share, of Ophthalmic Imaging Systems (the "Company"), to U.M. AccelMed, Limited Partnership ("AccelMed") at $0.70 per share of common stock.
These securities are owned directly by AccelMed and indirectly by A.M. AccelMed Management (2009) Ltd., the general partner of AccelMed (the "General Partner"), M. Arkin (1999) Ltd ("M. Arkin (1999)"), the beneficial owner of 80% of the outstanding shares of the General Partner, and Moshe Arkin, the sole director and the beneficial owner of 99.9% of the outstanding shares of M. Arkin (1999).
The filing of this Form 4 shall not be construed as an admission that the General Partner, M. Arkin (1999) or Mr. Arkin is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, the beneficial owner of any of the shares of common stock of the Company owned by AccelMed. Pursuant to Rule 16a-1, each of the General Partner, M. Arkin (1999) and Mr. Arkin disclaim beneficial ownership of the shares of the Company reported herein that are beneficially owned by AccelMed, except to the extent of their pecuniary interest therein.